154 related articles for article (PubMed ID: 36546737)
1. High Expression of CHST11 Correlates with Poor Prognosis and Tumor Immune Infiltration of Pancreatic Cancer.
Zhang P; Chen D; Cui H; Luo Q
Clin Lab; 2022 Dec; 68(12):. PubMed ID: 36546737
[TBL] [Abstract][Full Text] [Related]
2. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
[TBL] [Abstract][Full Text] [Related]
3. Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.
Tang P; Qu W; Wu D; Chen S; Liu M; Chen W; Ai Q; Tang H; Zhou H
J Immunol Res; 2021; 2021():3821055. PubMed ID: 34993253
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer with low SLC35A3 is associated with immune infiltrates and poor prognosis.
Lu S; Sun X; Tang H; Yu J; Wang B; Xiao R; Qu J; Sun F; Deng Z; Li C; Yang P; Yang Z; Rao B
Sci Rep; 2024 Jan; 14(1):329. PubMed ID: 38172565
[TBL] [Abstract][Full Text] [Related]
5. Effect of CHST11, a novel biomarker, on the biological functionalities of clear cell renal cell carcinoma.
Hu W; Chen Y; Zhang L; Guo X; Wei X; Shao Y; Wang D; Wu B
Sci Rep; 2024 Apr; 14(1):7704. PubMed ID: 38565604
[TBL] [Abstract][Full Text] [Related]
6. The CHST11 gene is linked to lung cancer and pulmonary fibrosis.
Li CH; Chan MH; Chang YC; Hsiao M
J Gene Med; 2022 Dec; 24(12):e3451. PubMed ID: 36181245
[TBL] [Abstract][Full Text] [Related]
7. Carbohydrate (Chondroitin 4) Sulfotransferase-11-Mediated Induction of Epithelial-Mesenchymal Transition and Generation of Cancer Stem Cells.
Behrens A; Jousheghany F; Yao-Borengasser A; Siegel ER; Kieber-Emmons T; Monzavi-Karbassi B
Pharmacology; 2020; 105(5-6):246-259. PubMed ID: 32344408
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer.
Zhang W; Yang C; Hu Y; Yi K; Xiao W; Xu X; Chen Z
Sci Rep; 2023 Feb; 13(1):2409. PubMed ID: 36765148
[TBL] [Abstract][Full Text] [Related]
9. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
Li A; Ye B; Lin F; Wang Y; Miao X; Jiang Y
Precis Clin Med; 2022 Jun; 5(2):pbac010. PubMed ID: 35694712
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of METTL3 in pancreatic cancer tissues associates with poor survival of the patients.
Li Y; Huang H; Zhu Y; Xu B; Chen J; Liu Y; Zheng X; Chen L
World J Surg Oncol; 2022 Sep; 20(1):283. PubMed ID: 36058919
[TBL] [Abstract][Full Text] [Related]
11. Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq.
Zhuang H; Chen X; Wang Y; Huang S; Chen B; Zhang C; Hou B
Cancer Immunol Immunother; 2022 Mar; 71(3):601-612. PubMed ID: 34279685
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
13. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract][Full Text] [Related]
14. Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer.
Wang H; Guo H; Sun J; Wang Y
Sci Rep; 2023 Aug; 13(1):13564. PubMed ID: 37604837
[TBL] [Abstract][Full Text] [Related]
15. Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.
Liu B; Fu T; He P; Du C; Xu K
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34143198
[TBL] [Abstract][Full Text] [Related]
16. The Pyroptosis-Related Gene Prognostic Index Associated with Tumor Immune Infiltration for Pancreatic Cancer.
Xie W; Li X; Yang C; Li J; Shen G; Chen H; Xiao SY; Li Y
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682857
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4 in pancreatic cancer.
Zhou X; Zhu X; Yao J; Wang X; Wang N
Invest New Drugs; 2021 Dec; 39(6):1469-1483. PubMed ID: 33983530
[TBL] [Abstract][Full Text] [Related]
19. Highly expressed carbohydrate sulfotransferase 11 correlates with unfavorable prognosis and immune evasion of hepatocellular carcinoma.
Xiong DD; Li JD; He RQ; Li MX; Pan YQ; He XL; Dang YW; Chen G
Cancer Med; 2023 Feb; 12(4):4938-4950. PubMed ID: 36062845
[TBL] [Abstract][Full Text] [Related]
20. IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer.
Huang W; Zhu L; Huang H; Li Y; Wang G; Zhang C
BMC Cancer; 2023 Feb; 23(1):116. PubMed ID: 36732736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
